Increased prevalence of thyroid disease in patients with antineutrophil cytoplasmic antibodies-associated vasculitis
File(s)Prendecki, Increased prevalence...docx (53.88 KB)
Accepted version
Author(s)
Prendecki, Maria
Martin, Leyre
Tanna, Anisha
Antonelou, Marilina
Pusey, Charles D
Type
Journal Article
Abstract
OBJECTIVE: Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) has been linked with thyroid disease as a result of antithyroid medications. We assessed the prevalence of thyroid disease in our patients with AAV. METHODS: Clinical records of 279 patients with AAV diagnosed between 1991 and 2014 were analyzed. RESULTS: Thyroid disease was identified in 21.5% of patients, but only 2 had previously received propylthiouracil. There was a greater proportion of female patients, patients with antimyeloperoxidase antibodies, and patients with renal disease in the group with thyroid disease. CONCLUSION: Our data show a higher prevalence of thyroid disease in patients with AAV than the general population. This was not attributable to antithyroid drugs.
Date Issued
2018-03-15
Date Acceptance
2017-11-21
Citation
Journal of Rheumatology, 2018, 45 (4)
ISSN
0315-162X
Publisher
Journal of Rheumatology
Journal / Book Title
Journal of Rheumatology
Volume
45
Issue
4
Copyright Statement
© 2018 The Journal of Rheumatology. This is a pre-copy-editing, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version is available online at: https://dx.doi.org/10.3899/jrheum.170661
Sponsor
Imperial College Healthcare NHS Trust- BRC Funding
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/29545453
PII: jrheum.170661
Grant Number
RDA04 79560
Subjects
1103 Clinical Sciences
1107 Immunology
1117 Public Health And Health Services
Arthritis & Rheumatology
Publication Status
Published online
Coverage Spatial
Canada
Article Number
ARTN 170661